Navigation Links
BioSyntech to conclude enrolment for pivotal BST-CarGel(R) trial in February 2009
Date:1/14/2009

LAVAL, QC, Jan. 14 /PRNewswire-FirstCall/ - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that it will conclude enrolment next month for the Canadian-European pivotal trial of its cartilage repair device, BST-CarGel(R). To date, the Company has enrolled more than 70 subjects and participating clinical sites will be permitted to enrol additional subjects until February 10th, 2009.

"With the certainty provided by this date, we are now sure that the final results from this pivotal trial will be available in the first quarter of 2010, once the last treated subject has completed their twelve-month follow up period. Furthermore, we are confident that the current number of enrolled subjects already represents a sufficiently powered study and that with this data we can meet the overall objectives of the study," said Michel Lagueux, Chairman of the Board of Directors. "At the same time, we remain sensitive to the fact that there are eligible individuals who still want a chance to participate in the study and we will work closely with our investigators over the next four weeks to ensure that as many as possible can be enrolled."

"I am very proud to be involved in the clinical development of this important new therapy in what is the largest randomized clinical trial for cartilage repair ever conducted in North America. Enrolment was certainly the greatest challenge, given our adherence to strict subject eligibility criteria, but in the end this rigour will ensure trial data of the highest quality and integrity," said Dr. William Stanish, Professor of Surgery at Dalhousie University in Halifax, Nova Scotia, and Principal Investigator for the trial.

Mr. Lagueux continued, "BioSyntech would like to acknowledge the team of over 25 orthopaedic surgeons and their support staff for their sincere dedication and perseverance in achieving this enrolment milest
'/>"/>

SOURCE BioSyntech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
2. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
3. West Concludes Agreement with Nektar
4. Workforce Alliance Concludes Three-Year Biotech Training Program
5. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
6. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)
7. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
8. Angiotech announces completion of Bio-Seal(TM) clinical trial enrolment
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Martek Biosciences Corporation (Nasdaq: MATK ) today announced ... year ended October 31, 2009. Revenues for the fourth ... in the fourth quarter of fiscal 2008. Net income ... the fourth quarter of fiscal 2009, a 5% increase ... in last year,s fourth quarter. The fourth quarter ...
(Date:12/16/2009)... among the Best in the Nation ,, ... proudly announces it has been granted Magnet(R) recognition ... Recognition Program(R). Magnet(R) is one of the highest ... can achieve, and places Hahnemann among the five ... achieved this prestigious distinction. ,, At 9:00 am ...
(Date:12/16/2009)... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), ... ( http://www.cordblood-america.com ) focused on bringing the ... insurance policy, to families nationwide and internationally, said ... a total of $1.4 million so far in ... eliminated for the year now tops $10 million. ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3
... May 15 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: ... focused on,endocrine therapy and oncology, today announced that ... Turpin, CA, will present a,company overview at the ... on Tuesday, May 20, 2008 at 9:40 am ...
... U.S. ... sales and marketing executive, NEWBURGH, NY, USA and ... i-LIMB Hand, the world,s first commercially,available, multi-articulating bionic hand, today ... developer of the unique,and lifelike prosthetic skin that Touch Bionics ...
... Diego electrical engineers have created experimental solar cells ... efficient thin-film solar cells of the future. , ... superhighways that carry electrons kicked loose by photons ... and this scenario could boost thin-film solar ...
Other Biology Technology:AEterna Zentaris to Present at Upcoming Rodman & Renshaw Global Healthcare Conference and AUA Annual Meeting 2Touch Bionics acquires LIVINGSKIN 2Touch Bionics acquires LIVINGSKIN 3Nanowires may boost solar cell efficiency, UC San Diego engineers say 2Nanowires may boost solar cell efficiency, UC San Diego engineers say 3Nanowires may boost solar cell efficiency, UC San Diego engineers say 4
(Date:12/16/2009)... the US have proposed a new method to ... findings, published in Animal Conservation , suggest ... behaviour, can benefit highly mobile marine predators such ... associated with setting conservation priorities for such mobile ... Erin Ashe, a PhD student at the University ...
(Date:12/16/2009)... winners of its student travel award to attend the ... Center in San Francisco, California, February 20-24, 2010. The ... scientific merit, with priority given to those who will ... receives a travel grant and will be recognized at ... recipients of the Student Travel Award are: , , Katherine ...
(Date:12/16/2009)... drop of water is a high priority for grape growers in ... vines have to be irrigated to make it through the growing ... the water applied to the vines zips right by the plants, ... of the water that is applied is lost below the vine ... vine roots," said Eve Hinckley, who worked on the project for ...
Breaking Biology News(10 mins):Zoning the ocean may help endangered whales to recover 2Zoning the ocean may help endangered whales to recover 3Biophysical Society announces winners of 2010 Student Travel Awards 2Biophysical Society announces winners of 2010 Student Travel Awards 3Biophysical Society announces winners of 2010 Student Travel Awards 4Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4Greater Boston unites to transform health care 49083 1Greater Boston unites to transform health care 49083 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 1Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 2Leading for Growth in the New Economic Reality Includes Vision and Innovation 12654 3Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 1Oral and Maxillofacial Surgeons Applaud Senator Mary Landrieu 28D LA 29 For Introducing Legislation to Require Insurance Coverage for Children With C 49078 2
... at the University of California, Santa Barbara, will present ... biology to assess climate-change related impacts on marine invertebrates ... the Advancement of Science in San Francisco on Sunday, ... sea urchins and mussels, important members of marine ecosystems. ...
... central nervous system (CNS) in animal evolution has puzzled ... the same ancestor, but their CNSs are different and ... had split during evolution. Researchers from the European Molecular ... vertebrate nervous system is probably much older than expected. ...
... variation among chimpanzees has found that the traditional, geography-based ... underpinned by significant genetic differences, two to three times ... populations. , In the April 2007 issue of ... Chicago, Harvard, the Broad Institute and Arizona State show ...
Other Biology News:The origin of the brain lies in a worm 2Gene study shows three distinct groups of chimpanzees 2
...
Anti-human Carcinoma Associated Antigen, Clone 115D8, Monoclonal Antibody Innate Immunity - Tumor Markers...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
Biology Products: